International Journal of Drug Delivery Technology
Volume 14, Issue 1

Pulsatile Drug Delivery Systems: A Comprehensive Review

Ravali V1, P Balaji2*

1School of Pharmaceutical Sciences, VISTAS, Pallavaram, Chennai, Tamil Nadu, India.

2Department of Pharmacology, School of Pharmaceutical Sciences, VISTAS, Pallavaram, Chennai, Tamil Nadu, India. 

Received: 19th November, 2023; Revised: 12th December, 2023; Accepted: 24th February, 2024; Available Online: 25th March, 2024

ABSTRACT

A sigmoidal drug release profile is formed when a pulsatile drug delivery system (PDDI) initiates drug administration and follows it up with rapid and complete drug release. It ensures the correct dosage of the drug is delivered at the right time and place. Pulsatile drug delivery is effective for treating asthma, arthritis, cancer, diabetes, epilepsy, hypertension, ulcers, and hypercholesterolemia, among others. There are many types of delivery systems in the pharmaceutical industry, including capsular, osmotic, single and multi-unit designs and membranes that are soluble and erodible. Innovations are directed toward conditions such as those requiring nocturnal dosing, high first-pass effects, and site-specific absorption in the gastrointestinal tract. In particular, these systems make dosing more convenient for patients, resulting in better compliance. As a result of the use of chronomodulated drug delivery systems, pharmaceutical therapy is more effective with a personalized approach.

Keywords: Pulsatile drug delivery, Circadian rhythms, Chronomodulation, Chronopharmacokinetics, Disease-specific timing. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.65

How to cite this article: Ravali V, Balaji P. Pulsatile Drug Delivery Systems: A Comprehensive Review. International Journal of Drug Delivery Technology. 2024;14(1):463-471.

REFERENCES

  1. Patel Vipul P, Soniwala Moinuddin M. Pulsatile Drug Delivery System for Treatment of Various Inflammatory Disorders-A International Journal of Drug Development & Research, 2012; 4(3):67-87.
  2. Sharma Ritika, Singh Arjun, Kumar Sunil, Jamil Faraz. Pulsatile drug delivery system. International Research Journal of Pharmacy, 2012; 3(7):103-107.
  3. Amidon GL, Leesman Pulsatile Drug Delivery System. US Patent No 5, 1993; 229,131.
  4. Sirisha VNL, Namrata M, Sruthi B, Harika I, Kiran kumar P, Kiran Y, Kumar Rao K.Pranavi. Pulsatile Drug Delivery System-A Review. International Journal of Pharmaceutical Research & Allied Sciences, 2012; 1(3): 13-23.
  5. Sachin Survase and Neeraj Kumar. Pulsatile drug delivery: Current scenario. CRIPS, 2007; 2:27‐33.
  6. Roy P, Shahiwala A. Multiparticulate formulation approach to pulsatile drug delivery: Current J Control Release, 2009;4(134):74–80.
  7. Matta Nalini Krishna reddy, Suresh bandari, Jaswanth Design and in-vitro characterization of ketoprofen core in cup pulsatile tablets for chronomodulated drug therapy. Indo American journal of pharmaceutical research, 2017;7(3): 8059-67.
  8. Pradip Karale. Pros and cons of pulsatile drug delivery system. Int. J.Pharm Drug Anal, 2015;3 (8):255-260
  9. Sinha VR, Bhinge JR, rachna kumria, Manoj kumar. Development of pulsatile systems for targeted drug delivery of Celecoxib for prophylaxis of colorectal cancer, 2006;13(3):221-5.
  10. Balaban SM, Pike JB, Smith JP, Baile CA.Osmotically Driven Del Devices with Pulsatile US Patent No. 5209746; 1993
  11. Tubati Vaniprasanna, Gopala Krishnamurthy T E, Sambasiva Ra A. An overview of chronotherapeutic drug delivery systems based on floating pulsatile concept. journal of advances in medical and pharmaceutical sciences, 2016;7(3):1-18.
  12. Mohamad A, Dashevsky A. pH-independent pulsatile drug delivery system based on hard gelatin capsules and coated with aqueous dispersion Aquacoat ECD. Eur J Pharm Biopharm, 2006;64:173-9.
  13. Hetal patel, Sonia Pandey, Vihari Patel, Ritesh Shah, Sanjay Twari. Pulsatile release of ketoprofen from compression coated tablets using Eudragit polymers; International journal of pharmacy and pharmaceutical sciences, 2016;8(2):224-9.
  14. Manish Kumar guptha, Swarnalatha saraf. Formulation and evaluation of pulsatile drug delivery system of ramipril for controlling morning spate of B.P.; Journal of pharmaceutical research, 2018;17(1): 1-8.
  15. Vijaya madhavi A, Rama brahma reddy D, Venugopal M, Srihari N, Chenniah, Koteswarao P. Formulation and evaluation of pulsatile drug delivery system of zafirlukast, Journal of drug delivery and therapeutics, 2020;10(2):122-8.
  16. Bussemer T, dashevsky A, Bodmeier A pulsatile drug delivery system based on pulsatile coated hard gelatin capsules; Journal of controlled release, 2003;331-39.
  17. Patel VR and Patel VP: Pulsatile Drug Delivery System-A Review. Int J Pharm Sci Res, 2015; 6(9): 3676-88.
  18. Modasiya Moin And Patel Vishnu M.: Pulsatile Drug Delivery System for Colon – A Review. International Journal of Research in Pharmaceutical and Biomedical Sciences, 2011; 2(3): 934-941.
  19. Krgel I, Bodmeier R. Evaluation of an enzyme containing capsular shaped pulsatile drug delivery system. Pharm Res, 1999;16(9):1424-29.
  20. Manjula B, Divyasri V, Shravya Ch, Maniteja yadav, Soujanya Ch. Formulation and evaluation of pulsatile drug delivery system of lisinopril; journal of drug delivery and therapeutics, 2019; 9(2):76-82.
  21. Vishal V, Bilaskar, Indrajeet S Patil, Omkar A patil, Girishchandra R Mandke, Shrinivas K Mohite. Design, development and optimization of pulsatile drug delivery of antihypertensive drug; international research journal of pharmaceutical and biosciences, 2018; 4(6):1-18.